Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anandan

Showing results (911-920 of 920) with videos related to

Pageof 92
Sort By:
You have reached the last page of results.This site can display upto 920 results.
Journal of Medicinal Chemistry|June 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> InhibitorXiaoshen Ma, David L Sloman, Ruchia Duggal, et al.
Plos Pathogens|April 28, 2023
Genomic analysis unveils genome degradation events and gene flux in the emergence and persistence of S. Paratyphi A lineagesJobin John Jacob, Agila K Pragasam, Karthick Vasudevan, et al.
Nanotoxicology|May 22, 2019
The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond - a reportVivien Stuttgen, Hugh E Giffney, Ayana Anandan, et al.
The Journal of Infectious Diseases|March 3, 2022
Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future ManagementBalaji Veeraraghavan, Agila K Pragasam, Pallab Ray, et al.
Journal of Medicinal Chemistry|April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug DesignXiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Journal of Medicinal Chemistry|November 22, 2011
Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivoZhong-Yue Sun, Theodros Asberom, Thomas Bara, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment OutcomesLauren Varney, Stephen Murtough, Marius Cotic, et al.
Journal of Medicinal Chemistry|December 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of PainGregory L Adams, Parul S Pall, Steven M Grauer, et al.
Lancet (London, England)|July 21, 2018
Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort studySamir K Saha, Stephanie J Schrag, Shams El Arifeen, et al.
Elife|September 12, 2023
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 <i>Salmonella</i> Typhi genomesMegan E Carey, Zoe A Dyson, Danielle J Ingle, et al.
Pageof 92

Showing results (911-920 of 920) with videos related to

Sort By:
Pageof 92
You have reached the last page of results.This site can display upto 920 results.
Journal of Medicinal Chemistry|June 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> InhibitorXiaoshen Ma, David L Sloman, Ruchia Duggal, et al.
Plos Pathogens|April 28, 2023
Genomic analysis unveils genome degradation events and gene flux in the emergence and persistence of S. Paratyphi A lineagesJobin John Jacob, Agila K Pragasam, Karthick Vasudevan, et al.
Nanotoxicology|May 22, 2019
The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond - a reportVivien Stuttgen, Hugh E Giffney, Ayana Anandan, et al.
The Journal of Infectious Diseases|March 3, 2022
Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future ManagementBalaji Veeraraghavan, Agila K Pragasam, Pallab Ray, et al.
Journal of Medicinal Chemistry|April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug DesignXiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Journal of Medicinal Chemistry|November 22, 2011
Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivoZhong-Yue Sun, Theodros Asberom, Thomas Bara, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Effect of <i>CYP1A2</i>, <i>CYP2D6</i>, and <i>CYP3A4</i> Variation on Antipsychotic Treatment OutcomesLauren Varney, Stephen Murtough, Marius Cotic, et al.
Journal of Medicinal Chemistry|December 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of PainGregory L Adams, Parul S Pall, Steven M Grauer, et al.
Lancet (London, England)|July 21, 2018
Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort studySamir K Saha, Stephanie J Schrag, Shams El Arifeen, et al.
Elife|September 12, 2023
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 <i>Salmonella</i> Typhi genomesMegan E Carey, Zoe A Dyson, Danielle J Ingle, et al.
Pageof 92